NYSEAMERICAN:INFU - InfuSystem Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $26.50
  • Forecasted Upside: 66.25 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$15.94
▼ -0.07 (-0.44%)

This chart shows the closing price for INFU by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New InfuSystem Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for INFU and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for INFU

Analyst Price Target is $26.50
▲ +66.25% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for InfuSystem in the last 3 months. The average price target is $26.50, with a high forecast of $27.00 and a low forecast of $26.00. The average price target represents a 66.25% upside from the last price of $15.94.

This chart shows the closing price for INFU for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in InfuSystem.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/9/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/7/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/5/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/4/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/4/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/30/2021Northland SecuritiesReiterated RatingBuy$27.00
4/26/2021Northland SecuritiesInitiated CoverageOutperform$27.00
12/29/2020SidotiInitiated CoverageBuy$26.00
8/31/2020Craig HallumInitiated CoverageBuy$28.00
6/9/2020Lake Street CapitalInitiated CoverageBuy$17.00
(Data available from 12/4/2016 forward)

News Sentiment Rating

0.07 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/8/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/7/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/6/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/5/2021
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/5/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/4/2021
  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/4/2021

Current Sentiment

  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
InfuSystem logo
InfuSystem Holdings, Inc. engages in the provision of health care services. It operates through the Integrated Therapy Services; and Durable Medical Equipment segments. The Integrated Therapy Services segment focuses on oncology such as providing ambulatory pumps to oncology offices, infusion clinics and hospital, and outpatient chemotherapy clinics. The Durable Medical Equipment segment involves in the rental, sale or leasing of pole-mounted and ambulatory infusion pumps to oncology practices, hospitals and other clinical settings. The company was founded in August 2005 and headquartered in Madison Heights, MI.
Read More

Today's Range

Now: $15.94
Low: $15.11
High: $16.49

50 Day Range

MA: N/A

52 Week Range

Now: $15.94
Low: $12.51
High: $23.26

Volume

97,981 shs

Average Volume

83,984 shs

Market Capitalization

$329.16 million

P/E Ratio

29.52

Dividend Yield

N/A

Beta

1.06

Frequently Asked Questions

What sell-side analysts currently cover shares of InfuSystem?

The following Wall Street analysts have issued stock ratings on InfuSystem in the last twelve months: Northland Securities, Sidoti, and Zacks Investment Research.
View the latest analyst ratings for INFU.

What is the current price target for InfuSystem?

2 Wall Street analysts have set twelve-month price targets for InfuSystem in the last year. Their average twelve-month price target is $26.50, suggesting a possible upside of 68.5%. Northland Securities has the highest price target set, predicting INFU will reach $27.00 in the next twelve months. Sidoti has the lowest price target set, forecasting a price of $26.00 for InfuSystem in the next year.
View the latest price targets for INFU.

What is the current consensus analyst rating for InfuSystem?

InfuSystem currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe INFU will outperform the market and that investors should add to their positions of InfuSystem.
View the latest ratings for INFU.

What other companies compete with InfuSystem?

How do I contact InfuSystem's investor relations team?

InfuSystem's physical mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier's listed phone number is (124) 291-1210. The official website for InfuSystem is ir.infusystem.com.